Finance

Beta
Lists
ADXN:SWX
Addex Therapeutics Ltd
CHF 0.040
-6.54%
(-0.0028) 1D
Jul 17, 5:31:48 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for ADXN...
Open
CHF 0.04
High
CHF 0.04
Low
CHF 0.04
Mkt. cap
9.36M
Avg. vol.
156.95K
Volume
20.87K
52-wk high
CHF 0.08
52-wk low
CHF 0.03
EPS
-CHF 0.06
Shares outstanding
218.65M
No. of employees
3
Open
CHF 0.04
High
CHF 0.04
Low
CHF 0.04
Mkt. cap
9.36M
Avg. vol.
156.95K
Volume
20.87K
52-wk high
CHF 0.08
52-wk low
CHF 0.03
EPS
-CHF 0.06
Shares outstanding
218.65M
No. of employees
3
News stories
From sources across the web
About Addex Therapeutics Ltd
CEO-
Employees3
Founded2002
Headquarters-
SectorPharmaceutical industry
Websiteaddextherapeutics.com
Last report
Jun 25, 2026
Fiscal period
Q1 2026
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
7.69K / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
36.38K
49.60K
15.83K
7.69K
Cost of goods sold
234.45K
228.32K
52.81K
36.13K
Cost of revenue
234.45K
228.32K
52.81K
36.13K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
534.82K
517.45K
742.28K
451.39K
Operating expense
534.82K
517.45K
742.28K
451.39K
Total operating expenses
769.27K
745.78K
795.09K
487.52K
Operating income
-732.90K
-696.18K
-779.26K
-479.83K
Other non operating income
-
-
-
-
EBT including unusual items
-1.96M
-1.58M
-1.83M
-1.71M
EBT excluding unusual items
-1.96M
-1.58M
-1.83M
-1.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.84M
-1.58M
-1.84M
-1.71M
Net profit margin
-5,061.62%
-3,179.90%
-11,604.47%
-22,256.39%
Earnings per share
-
-
-
-
Interest and investment income
3.00
-
-
-
Interest expense
-829.00
-472.00
-575.00
-956.00
Net interest expenses
-826.00
-472.00
-575.00
-956.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-730.78K
-696.07K
-779.16K
-479.72K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer